BMS and Compugen join forces on solid tumour clinical trials

BMS and Compugen will enter into a clinical collaboration to evaluate therapeutic regimen in advanced solid tumours.  The clinical trial collaboration between Bristol-Myers Squibb and Compugen...

Follow us

Link between dementia and spontaneous errors in DNA

Only a small proportion of cases of dementia are thought to be inherited – the cause of the vast majority is unknown. Now, a...

New standards launched to improve public involvement in research

New national standards to improve the quality of public involvement in research.
painter removing star from EU flag due to Brexit and the UK life science industry 

Brexit and the UK life science industry

Damon Culbert looks at Brexit and the UK life science industry with particular consideration to the impact of immigration. For many industry professionals, Britain’s plans to leave the European...
Lady of justice showing High Court ruling against Novartis and Bayer

High Court ruling against Novartis and Bayer: Implications

Claudia Rubin and Tom Jaggs explore the implications of the High Court ruling against Novartis and Bayer for pharma. High Court ruling against Novartis and...

NHS long-term plan: Growing importance of prevention medicine

“The challenge now is for the NHS to respond to this changing landscape and to focus on preventing as well as treating the conditions...

Ashfield Healthcare Communications appoints new Global Commercial Director

Ashfield, part of UDG Healthcare, has appointed Ben Beckley as Global Commercial Director of Ashfield Healthcare Communications. He will be based in Boston, USA. Beckley...

Jobs of the week

Man taking stars from the EU flag to demonstrate the impact of brexit

The impact of Brexit & EMA relocation on pharma

With the European Medicines Agency (EMA) relocating to Amsterdam before 29 March 2019, Pf sought the views of industry leaders to discuss the impact of Brexit...

The Pf Power List: Who is shaping the pharma & healthcare sector?

Pf Power List. Our industry is moving: rapid medical advancement, an ever-changing NHS and the evolution of digital health are combining to transform pharma...

How will the NHS’s evolution towards integrated care unfold?

Triducive’s Tim Warren explores how pharma can succeed within the newly emerging integrated commissioning landscape. As Prime Minister Theresa May promises £20 billion more funding...